CURLF
Price
$2.94
Change
-$0.14 (-4.55%)
Updated
Aug 14 closing price
Capitalization
2.24B
87 days until earnings call
GTBIF
Price
$8.63
Change
-$0.34 (-3.79%)
Updated
Aug 14 closing price
Capitalization
1.98B
Interact to see
Advertisement

CURLF vs GTBIF

Header iconCURLF vs GTBIF Comparison
Open Charts CURLF vs GTBIFBanner chart's image
Curaleaf
Price$2.94
Change-$0.14 (-4.55%)
Volume$2.35M
Capitalization2.24B
Green Thumb Industries
Price$8.63
Change-$0.34 (-3.79%)
Volume$689.6K
Capitalization1.98B
CURLF vs GTBIF Comparison Chart in %
Loading...
CURLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GTBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CURLF vs. GTBIF commentary
Aug 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CURLF is a Buy and GTBIF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 15, 2025
Stock price -- (CURLF: $2.94 vs. GTBIF: $8.63)
Brand notoriety: CURLF and GTBIF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CURLF: 225% vs. GTBIF: 123%
Market capitalization -- CURLF: $2.24B vs. GTBIF: $1.98B
CURLF [@Pharmaceuticals: Generic] is valued at $2.24B. GTBIF’s [@Pharmaceuticals: Generic] market capitalization is $1.98B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.83B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CURLF’s FA Score shows that 0 FA rating(s) are green whileGTBIF’s FA Score has 1 green FA rating(s).

  • CURLF’s FA Score: 0 green, 5 red.
  • GTBIF’s FA Score: 1 green, 4 red.
According to our system of comparison, both CURLF and GTBIF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CURLF’s TA Score shows that 3 TA indicator(s) are bullish while GTBIF’s TA Score has 4 bullish TA indicator(s).

  • CURLF’s TA Score: 3 bullish, 3 bearish.
  • GTBIF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CURLF and GTBIF are a good buy in the short-term.

Price Growth

CURLF (@Pharmaceuticals: Generic) experienced а +64.05% price change this week, while GTBIF (@Pharmaceuticals: Generic) price change was +23.64% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.42%. For the same industry, the average monthly price growth was +69.33%, and the average quarterly price growth was +80.16%.

Reported Earning Dates

CURLF is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.42% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CURLF($2.24B) has a higher market cap than GTBIF($1.98B). CURLF YTD gains are higher at: 88.237 vs. GTBIF (5.630). GTBIF has higher annual earnings (EBITDA): 368M vs. CURLF (223M). GTBIF has more cash in the bank: 211M vs. CURLF (122M). GTBIF has less debt than CURLF: GTBIF (526M) vs CURLF (847M). CURLF has higher revenues than GTBIF: CURLF (1.31B) vs GTBIF (1.14B).
CURLFGTBIFCURLF / GTBIF
Capitalization2.24B1.98B113%
EBITDA223M368M61%
Gain YTD88.2375.6301,567%
P/E RatioN/A78.45-
Revenue1.31B1.14B115%
Total Cash122M211M58%
Total Debt847M526M161%
FUNDAMENTALS RATINGS
CURLF vs GTBIF: Fundamental Ratings
CURLF
GTBIF
OUTLOOK RATING
1..100
2215
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
84
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9587
PRICE GROWTH RATING
1..100
3438
P/E GROWTH RATING
1..100
1009
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CURLF's Valuation (50) in the null industry is somewhat better than the same rating for GTBIF (84). This means that CURLF’s stock grew somewhat faster than GTBIF’s over the last 12 months.

CURLF's Profit vs Risk Rating (100) in the null industry is in the same range as GTBIF (100). This means that CURLF’s stock grew similarly to GTBIF’s over the last 12 months.

GTBIF's SMR Rating (87) in the null industry is in the same range as CURLF (95). This means that GTBIF’s stock grew similarly to CURLF’s over the last 12 months.

CURLF's Price Growth Rating (34) in the null industry is in the same range as GTBIF (38). This means that CURLF’s stock grew similarly to GTBIF’s over the last 12 months.

GTBIF's P/E Growth Rating (9) in the null industry is significantly better than the same rating for CURLF (100). This means that GTBIF’s stock grew significantly faster than CURLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CURLFGTBIF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
CURLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GTBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VAFCX25.70N/A
N/A
Invesco American Franchise C
SHXPX15.43N/A
N/A
American Beacon Shapiro Equity Opps Inv
TEMFX9.24N/A
N/A
Templeton Foreign A
IVOIX19.73N/A
N/A
Macquarie Mid Cap Income Opps I
SPMJX5.82-0.01
-0.17%
Invesco SteelPath MLP Alpha Plus R

CURLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CURLF has been closely correlated with GTBIF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if CURLF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CURLF
1D Price
Change %
CURLF100%
-4.66%
GTBIF - CURLF
82%
Closely correlated
-3.79%
TCNNF - CURLF
80%
Closely correlated
-9.94%
VRNOF - CURLF
78%
Closely correlated
+2.04%
CRLBF - CURLF
76%
Closely correlated
-10.76%
TSNDF - CURLF
75%
Closely correlated
-7.85%
More

GTBIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GTBIF has been closely correlated with TCNNF. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if GTBIF jumps, then TCNNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GTBIF
1D Price
Change %
GTBIF100%
-3.79%
TCNNF - GTBIF
83%
Closely correlated
-9.94%
CURLF - GTBIF
82%
Closely correlated
-4.66%
VRNOF - GTBIF
80%
Closely correlated
+2.04%
TSNDF - GTBIF
78%
Closely correlated
-7.85%
CRLBF - GTBIF
71%
Closely correlated
-10.76%
More